|
|
Trends Parasitol. 2008 November; 24(11): 525–530. doi: 10.1016/j.pt.2008.08.001. | PMCID: PMC2764380 |
Gametocytes: insights gained during a decade of molecular monitoring Hamza A. Babiker,1,2 Petra Schneider,2 and Sarah E. Reece2 1Biochemistry Department, Faculty of Medicine, Sultan Qaboos University, Alkhod, PO Box 35, Muscat, Code 123, Oman 2Institutes of Evolution, Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, EH9 3JT, UK This document was posted here by permission of the publisher.
At the time of the deposit, it included all changes made during peer review,
copy editing, and publishing. The U. S. National Library of Medicine is responsible
for all links within the document and for incorporating any publisher-supplied
amendments or retractions issued subsequently. The published journal article,
guaranteed
to be such by Elsevier, is available for free, on ScienceDirect, at: http://dx.doi.org/10.1016/j.pt.2008.08.001In vertebrate hosts, malaria parasites produce specialized male and female sexual stages (gametocytes). Soon after being taken up by a mosquito, gametocytes rapidly produce gametes and, once mated, they infect their vector and can be transmitted to new hosts. Despite being the parasite stages that were first identified (over a century ago), gametocytes have remained elusive, and basic questions remain concerning their biology. However, the postgenomic era has substantiated information on the specialized molecular machinery of gametocytogenesis and expedited the development of molecular tools to detect and quantify gametocytes. The application of such highly sensitive and specific tools has opened up novel approaches and provided new insights into gametocyte biology. Here, we review the discoveries made during the past decade, highlight unanswered questions and suggest new directions. The dawn of molecular detection Malaria is a debilitating disease that is responsible for between one and three million deaths annually, across tropical and subtropical climatic zones. The causative agents, Plasmodium parasites, replicate asexually in the blood of their vertebrate hosts, and a proportion of these asexually produced parasites differentiate into male and female sexual stages (gametocytes). Whereas the asexual stage in the life cycle of the parasite is responsible for clinical disease, gametocytes are responsible for transmission from host to vector. When taken up in the bloodmeal of a vector, male and female gametocytes immediately leave their red blood cells and produce gametes, which then mate and differentiate into stages that are infective to mosquitoes. Parasites then progress through several developmental stages in their vector, culminating in sporozoite stages that move to the salivary glands, ready to be transmitted to new hosts. Although sexual reproduction in Plasmodium parasites was discovered over a century ago, key questions about gametocyte biology remain. For example, the investment in gametocytes (the density of gametocytes relative to asexual forms, or conversion rate) and their sex ratio (the proportion of gametocytes that are male) both vary extensively across and within parasite species, populations and individual infections. Progress is being made in uncovering the genes and proximate mechanisms responsible [1–4], but the ultimate evolutionary explanations for this variation remain poorly understood [5–8]. Given the essential role that gametocytes have in transmission and the drive to develop clinical interventions that disrupt sexual reproduction, why are there still fundamental unanswered questions about their biology? This is, at least in part, because gametocytes occur at much lower densities than asexual parasites, which makes them more difficult to detect. However, with the development of a gametocyte-specific PCR assay for P. falciparum in 1999 [9], the elusive gametocytes became detectable with greater sensitivity. Over the past decade [10], the continued development of molecular techniques has provided assays that are sensitive enough to: (i) detect and quantify gametocytes at low densities [9,11–13]; (ii) differentiate gametocytes at early and late stages of development [14]; (iii) quantify gametocytes produced by different parasite genotypes in multi-genotype infections [15,16]; (iv) determine the expression pattern of sexual-stage-specific genes [17]; and (v) distinguish between male and female gametocytes, including those produced by different genotypes in multi-genotype infections [18]. These assays have stimulated major lines of research, from epidemiological and population-level surveys of gametocyte carriers and their transmission potential to the performance and behaviour of individual parasite genotypes during infections and the assessment of transmission outcomes after anti-malarial therapy. Here, we provide an overview of the insights into Plasmodium gametocyte and transmission biology gained using molecular tools over the past decade ( Box 1). We suggest approaches to tackle some of the remaining questions and discuss the implications for control measures. Box 1.Developments and discoveries made during a decade of molecular gametocyte detection1999 Qualitative detection of P. falciparum gametocytes by reverse transcriptase (RT)-PCR confirms the presence of submicroscopic gametocytes [9]. 2000 Qualitative genotype-specific RT-PCR to detect P. falciparum gametocytes reveals that multiple co-infecting genotypes within an infection can simultaneously produce gametocytes [15]. 2002 RT-PCR used to show that gametocytes at submicroscopic densities are present in infections during the transmission-free season in Sudan [19]. 2004 Quantitative nucleic acid sequence-based amplification (NASBA) developed to distinguish P. falciparum gametocytes at early and late stages of development reveals that gametocytes are produced soon after parasites are released from the liver [14]. 2005 Genotype-specific RT-PCR reveals that multi-genotype infections of P. falciparum persist and produce gametocytes for longer during transmission-free season than single-genotype infections [20]. 2006 Real-time quantitative assays developed to quantify gametocyte densities for P. falciparum [12] and P. chabaudi [13]. In P. falciparum, gametocytes at submicroscopic densities are common post-treatment and these infections contribute considerably to transmission [12,21]. Previous beliefs, based on microscopic data, are that treatment can result in increased gametocyte prevalence. Molecular assays show that this post-treatment peak in gametocyte prevalence reflects an increase in gametocyte density to levels that are more likely detected by microscopy [12,53]. Furthermore, artemisinin-based combination therapy (ACT) reduces gametocyte density and the proportion of mosquitoes infected but does not affect the proportion of patients with infectious gametocytes (infectious reservoir) [12,21]. 2007 Real-time RT-PCR reveals that P. chabaudi genotypes do not alter their gametocyte conversion rate in response to competition with a co-infecting genotype [65]. However, when competition occurs between a drug-resistant and a drug-sensitive genotype and infections are treated to clear the sensitive genotype, the resistant genotype achieves higher gametocyte densities than when in single-genotype infections [16]. Quantitative genotype-specific and sex-specific RT-PCR developed to quantify P. chabaudi gametocyte densities and sex ratios of individual genotypes in multi-genotype infections [18]. In P. falciparum, more gametocyte carriers are detected using QT-NASBA than microscopy in Burkina Faso [22] and Tanzania [23,24], and submicroscopic gametocytes contribute to transmission [26]. Primaquine treatment can clear all gametocytes remaining after treatment with ACT and sulphadoxine–pyrimethamine [23]. 2008 Quantitative genotype-specific and sex-specific RT-PCR for P. chabaudi reveals: genetic variation for patterns of sex-ratio variation observed throughout infections; sex-ratio patterns correlate with host anaemia, and total parasite and gametocyte density; and genotypes increase their investment in male, relative to female, gametocytes in response to the presence of co-infecting genotypes. Genotype-specific RT-PCR for P. falciparum reveals that minority genotypes in multiple-clone infections are able to transmit to mosquitoes [25]. In mixed-species infections with Plasmodium malariae, P. falciparum gametocyte densities are higher than in single-species infections [79]. |
The ‘growing’ reservoir of infectious gametocytes Surveys based on the examination of blood smears by microscopy have consistently shown that gametocytes are observed only in a subset of infected patients [7]. However, malaria parasites can transmit from these supposedly ‘non-infectious’ hosts, and the presence of gametocytes at extremely low densities has long been suspected [5]. Molecular-amplification-based techniques are sensitive enough to detect and quantify gametocytes at very low densities (e.g. 0.02–10 gametocytes per microlitre [12]) and have confirmed the presence of gametocytes at densities too low to be detected by standard microscopy methods. We refer to gametocyte densities that are unlikely to be detected by microscopy but can be detected by molecular methods as ‘submicroscopic’. Submicroscopic gametocyte carriers exist at a higher frequency than expected and at all levels of endemicity [12,19–25], and, most importantly, make considerable contributions to transmission [26]. The successful infection of vectors is generally positively correlated to gametocyte density [26–31], but the probability of mosquito infection at low gametocyte densities is higher than that predicted by simple linear relationships. This raises the possibility that gametocytes can cluster in the capillaries [32–34] or that per-gametocyte infectivity is density-dependent. The second scenario could occur if transmission-blocking immune factors are more likely to be found in bloodmeals from high-density infections [33]. In addition to the density and sex ratio of gametocytes, transmission success is also influenced by the timing of gametocyte production. Molecular assays have revealed that this is of particular importance in areas with seasonal transmission because asymptomatic infections with submicroscopic gametocyte densities are likely to be the source of annual epidemics in these areas [20,35]. These infections continue to produce gametocytes at low levels throughout the transmission-free season, and parasites might be capable of increasing the gametocyte conversion rate in response to cues that indicate the start of the transmission season. There are many cues that parasites could use as correlates of the transmission season, but studies testing whether parasites respond to the presence of mosquitoes probing their hosts (for example, detecting factors produced from mosquito salivary glands) have given mixed results. There is some support for the hypothesis that parasites of the rodent malaria Plasmodium chabaudi increase investment in gametocytes [36], but no change was observed when this experiment was repeated in a larger-scale study with P. chabaudi and Plasmodium vinckei [37]. It is not yet clear why parasites in these chronic infections continue to produce gametocytes throughout the transmission-free season [19,20]. Investigating whether the conversion to gametocytes during the transmission-free season is a constraint (by-product) of the cell cycle or an adaptation is a key question. Understanding how host immune responses regulate parasitaemia in chronic infections might help to explain patterns of gametocyte investment. For example, investing in gametocytes could ensure that the asexual parasite density stays low during recrudescence, which might enable parasites to keep their total numbers below the threshold for the reactivation of the immune system. Alternatively, these chronic infections often comprise multiple genotypes, and competition between parasites could shape the patterns of gametocyte investment [38]. Hostile in-host environmental conditions An increase in gametocyte conversion has been observed in response to drug therapy and various forms of host anaemia [16,39–46]. Gametocyte conversion is increased when reticulocytes (immature erythrocytes) are added to P. falciparum culture [46] and, in the rodent malarias P. chabaudi and Plasmodium berghei, when reticulocyte release and production is stimulated by administering phenylhydrazine to their hosts [47]. More recently, experimental infections have implicated erythropoietin (EPO), a hormone produced by anaemic hosts, as a possible parasite cue for gametocyte conversion and sex-ratio alteration [43,44]. Because correlations between gametocyte density and reticulocyte density (positive correlation) or haematocrit (negative correlation) have been documented in natural [48] and experimental infections [49], elucidating whether parasites are responding to EPO or reticulocytes is necessary to determine what factors parasites monitor throughout their infections. Intriguingly, P. chabaudi, a species that can infect reticulocytes, responds to EPO by upregulating conversion, but P. vinckei, which only infects mature erythrocytes, responds by altering its sex ratio instead. This indicates that the host-cell preference of parasite species also influences their patterns of conversion. These problems could be tackled by using molecular assays to detect young gametocytes and accurately quantify conversion. Elevated gametocyte densities after exposure to anti-malarial drugs have been observed in the rodent malarias P. chabaudi and P. vinckei [40–42] and in the human malaria P. falciparum [12,21,45,50–55]. In the rodent malarias, this response is thought to be due to increased gametocyte conversion, but in P. falciparum, post-treatment peaks of gametocyte density often occur sooner than the development time required for a new cohort to appear. Molecular methods have provided data [12,53] to support the hypothesis [45] that the drug-induced release of sequestered gametocytes occurs, rather than an increase in conversion. Whether mature (infectious) or immature (non-infectious) gametocytes are released from sequestration is not known, but this could be investigated by monitoring post-treatment gametocyte cohorts by using molecular assays that detect transcripts of early- and late-stage gametocytes. Furthermore, whether this variation in sequestration time represents a by-product of drug action or is an adaptive shortening of development time remains to be tested. Why should rodent, but not human, malaria parasites increase conversion? Clues could lie in the considerable difference in the gametocyte development time of these taxa. Rodent malaria gametocytes take 36–48 h to reach maturity, so these species might be able to produce a timely response to the rapid action of drugs, whereas the 7–10 days that are required for P. falciparum gametocytes to develop might constrain their ability to keep up with rapid or unpredictable drug action and would certainly result in changes to conversion being more difficult to correlate with events in the past. Gametocytes in multigenotype infections Most malaria infections of humans and other animals contain many genotypes [49,56–60] owing to sequential infection in areas of high transmission intensity or the simultaneous acquisition of multiple genotypes from a single mosquito bite. Molecular assays have revealed that individual genotypes within an infection produce gametocytes simultaneously and, in multigenotype infections, this process lasts longer than in single infections [20]. Understanding how the genetic complexity of co-infecting parasites influences gametocyte dynamics and their infectivity to mosquitoes is central to understanding transmission dynamics at the population level. In addition, synthesis of data on the performance of individual genotypes during multi-genotype infections and the probability of their simultaneous transmission to mosquitoes will provide better estimates of recombination rates [61]. In addition to their ability to detect gametocytes at low density, molecular assays also enable the discrimination and quantification of gametocytes produced by different genotypes within the same infection. So far, genotype-specific assays have been developed for P. falciparum and P. chabaudi gametocytes [15,16]. The application of these assays has revealed that co-infecting genotypes can simultaneously produce gametocytes and transmit, throughout both clinical and asymptomatic P. falciparum infections [25]. The presence and density of co-infecting genotypes can fluctuate markedly throughout their infections [35,57] as a result of within-host competition. For example, the genotypes that are best at competing for red blood cells or evading the immune system might have a transmission advantage over their co-infecting competitors. Transmission studies have supported this prediction by showing that although minority genotypes can transmit [62], the transmission of competing genotypes is reduced [63]. Furthermore, when competition occurs between drug-resistant and drug-sensitive genotypes, the resistant genotype tends to be at a disadvantage in the absence of drugs [16]. Laboratory studies using P. chabaudi have shown that, in general, virulent (majority) genotypes have a competitive advantage and tend to suppress the growth of less-virulent (minority) competitors [16,63–65]. Faster-growing genotypes could out-compete others through resource competition or by eliciting an immune response that was sufficient to clear minority, but not majority, genotypes, and these two mechanisms are not mutually exclusive. By keeping conversion to gametocytes low, fast-growing genotypes can maximize their investment in asexual replication and, thus, acquire a greater share of host red blood cells than their competitors [38]. Furthermore, genotypes that maintain high asexual densities relative to gametocytes could shelter their gametocytes from strain-specific immune responses acting in the host or minimize the availability of gametocyte antigens that elicit the development of transmission-blocking immune factors. These hypotheses remain to be tested but could reveal that lower gametocyte conversion has evolved in areas with high transmission, when compared to areas of low transmission [38]. However, in P. chabaudi, experiments indicate that genotypes do not conditionally alter conversion when in a single- or a double-genotype infection [18,65]. Most laboratory-based studies have focused on gametocyte dynamics during the acute phase of infections, but the transmission advantage of virulent (majority) genotypes might not extend into the chronic phase because the development of anaemia and the immune response could alter the balance between asexual replication and gametocyte density. Quantifying genotype-specific investment into gametocytes during chronic infections in which co-infecting genotypes vary in competitive ability would be useful. Assays designed specifically to detect the gametocytes of minority genotypes will avoid the problem of over-amplifying majority genotypes and, thus, missing the minority ones of interest [66]. However, although genotype-specific assays can be designed for experimental infections with well-identified genotypes, unknown genotypes, which make the identification of suitable genotype-specific assays more difficult, are expected in field studies. Sophisticated sex allocation Successful transmission to vectors is related not only to the density of infectious gametocytes but also to their sex ratio. Sex ratios in malaria parasites are generally female-biased [8], and evolutionary theory predicts that sex ratios reflect the inbreeding rate [67–69]. When taken up in a bloodmeal of a vector, gametocytes must rapidly form gametes, and fertilization can occur between gametes from the same (inbreeding) or different (outbreeding) genotypes. Each male gametocyte can differentiate into up to eight gametes, whereas each female gametocyte differentiates to form a single gamete. Therefore, because males can each fertilize more than one female, a female-biased sex ratio maximizes fertilization success and, thus, represents the most efficient allocation of resources [68,69]. However, this is only the case when the gametocytes in a bloodmeal are genetically related and inbreeding occurs. In this situation, by producing the minimum number of male gametocytes necessary to fertilize the females, parasites are reducing competition for mates between related males and they are maximizing the number of females with which they can mate. Conversely, when infections are composed of several genotypes, the greatest fitness benefits come from increasing investment in male gametocytes. This is because a genotype will gain more fertilizations from each male gametocyte (because each will mate with several females) than from each female (which can be mated only once) [68,69]. The application of this theory to malaria parasites has been rather controversial [8,70] because it does not explain why sex ratios vary throughout infections [18] or why population sex ratios in related Apicomplexans do not correspond to their inbreeding rate (see, for example, Ref. [71]). The strongest support for this theory in other taxa has come from experimental tests that show that individuals can evaluate the inbreeding rate and facultatively adjust their sex ratio accordingly [72]. The recent development of molecular assays that are both genotype- and sex-specific has enabled analogous experiments and revealed that P. chabaudi genotypes can evaluate their inbreeding rate and adjust their sex ratio as predicted [49]. More broadly, this also reveals that P. chabaudi parasites can discriminate genetically identical clone-mates from con-specific genotypes in their infections. Whether they are able to ‘discriminate kin’ directly (for example, using ‘quorum sensing’) or indirectly (by using some information about their environment, such as the presence of different immune factors) is yet to be investigated. The use of sex-specific assays to track sex ratios throughout single-genotype infections of P. chabaudi has also revealed that patterns of sex allocation during infections correlate with factors such as gametocyte density and host anaemia [49]. Specifically, more males are produced when gametocyte and red blood cell density are low, and reticulocyte density is high. When sex ratios are very female-biased and gametocyte density is low or hosts are anaemic, there is a risk of too few males being taken up in bloodmeals to fertilize the females. Furthermore, even if there are plenty of gametocytes, transmission-blocking immune factors could impair the ability of males to make viable gametes, and the development of such immune factors has been proposed to coincide with anaemia [43]. Therefore, in either of these scenarios, genotypes must ensure that their females are fertilized by investing in extra males (more than expected from their inbreeding rate alone) [8,73]. To date, the experimental work has been focused largely on P. chabaudi, so developing assays to test these hypotheses more generally is required. Molecular assays to discriminate different genotypes in natural infections of the lizard malaria, Plasmodium mexicanum, have already been developed, and field experiments with this system are possible [74]. Over the past decade, molecular methods have superseded traditional microscopy because they have enabled, for the first time, gametocytes at low densities to be readily quantified and gametocytes produced by parasites of different genotypes in multi-genotype infections to be distinguished. Molecular methods have also facilitated the reliable and rapid detection and quantification of gametocytes at different developmental stages and sexes. Some long-standing questions have been answered and new lines of research have developed. Gametocytes might no longer be elusive, but many mysteries and challenges remain. For example, despite recent advances in mapping genes that are involved in gametocytogenesis [1], many aspects of gametocyte biology are unclear. One such outstanding question is, ‘How is the sex of gametocytes determined?’ [75]. A better understanding of how sex allocation is influenced by changes in anaemia, immune factors, genotype multiplicity and variable environmental factors (such as mosquito abundance and drug pressure) could provide valuable clues. This could be achieved by integrating expression profiles of a large number of gametocyte- and sex-specific proteins of Plasmodium parasites into methods to analyse gametocytes in different stages of development, maturity and sexes. Testing when, why and how gametocyte conversion is shaped by environmental factors and by competition in multi-genotype infections is also necessary. This requires differentiating gametocytes produced by different genotypes, which is a considerable challenge in natural infections. However, a combination of several gametocyte-specific quantification assays based on unlinked single-copy polymorphic genes will reduce the probability of underestimating the number of gametocyte-producing genotypes in natural infections. By continuing to develop and refine molecular methods, we expect that the next decade will reveal a deeper understanding of gametocyte biology and of the mating biology of gametes. A better understanding of factors that influence gametocyte investment and transmission is essential to the development and evaluation of clinical interventions that disrupt sexual reproduction in Plasmodium. For example, asymptomatic infectious individuals are of major importance from a public health perspective. The identification of ‘gametocyte carriers’ and factors that can lead to increased transmission has been considered very important for determining the sources of infection in a community. With many asymptomatic carriers contributing to transmission, the feasibility and public health impact of gametocyte-targeted control, such as intermittent preventive treatment and mass treatment [23,76,77] might need to be revised. Especially in areas with marked seasonal transmission, a reduction of the infectious reservoir over consecutive years could reduce the basic reproduction rate ( R0; the number of future cases derived from one infective case at the present time) to a controllable level. However, a limitation to this approach in the short term is the presence of drug-resistant parasites that can overcome the effect of drugs used and escalate in frequency in the face of drug pressure [76,77]. For the determination of malaria-control strategies, outcomes related to transmission, including post-intervention gametocyte prevalence and density, should be assessed and measures to counter increased gametocytaemia should be considered. Therefore, molecular gametocyte detection and quantification should be added to existing protocols for the evaluation of control strategies, including anti-malarial drugs efficacy [78]. We thank the BBSRC, Wellcome Trust, MRC (UK) and Sultan Qaboos University (Oman) for funding and four anonymous reviewers for their insightful comments. 1. Dixon M.W.A. Sex in Plasmodium: a sign of commitment. Trends Parasitol. 2008;24:168–175. [PubMed] 2. Kooij T.W., Matuschewski K. Triggers and tricks of Plasmodium sexual development. Curr. Opin. Microbiol. 2007;10:547–553. [PubMed] 3. Pradel G. Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies. Parasitology. 2007;134:1911–1929. [PubMed] 4. Alano P. Plasmodium sexual stage antigens. Parasitol. Today. 1991;7:199–203. [PubMed] 5. Drakeley C. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol. 2006;22:424–430. [PubMed] 6. Paul R.E.L. The evolutionary ecology of Plasmodium. Ecol. Lett. 2003;6:866–880. 7. Talman A.M. Gametocytogenesis: the puberty of Plasmodium falciparum. Malaria J. 2004;3:14p. 8. West S.A. Evolution of gametocyte sex ratios in malaria and related apicomplexan (protozoan) parasites. Trends Parasitol. 2001;17:525–531. [PubMed] 9. Babiker H.A. Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. Mol. Biochem. Parasitol. 1999;99:143–148. [PubMed] 10. Babiker H.A., Schneider P. Application of molecular methods for monitoring transmission stages of malaria parasites. Biomed. Mat. 2008;3:34007. 11. Paganotti G.M. Genetic complexity and gametocyte production of Plasmodium falciparum in Fulani and Mossi communities in Burkina Faso. Parasitology. 2006;132:607–614. [PubMed] 12. Schneider P. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int. J. Parasitol. 2006;36:403–408. [PubMed] 13. Wargo A.R. Plasmodium chabaudi: reverse transcription PCR for the detection and quantification of transmission stage malaria parasites. Exp. Parasitol. 2006;112:13–20. [PubMed] 14. Schneider P. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol. Biochem. Parasitol. 2004;137:35–41. [PubMed] 15. Menegon M. Genotyping of Plasmodium falciparum gametocytes by reverse transcriptase polymerase chain reaction. Mol. Biochem. Parasitol. 2000;111:153–161. [PubMed] 16. Wargo A.R. Competitive release and facilitation of drug-resistance parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl. Acad. Sci. U. S. A. 2007;104:19914–19919. [PubMed] 17. Niederwieser I. Plasmodium falciparum: expression of gametocyte-specific genes in monolayer cultures and malaria-positive blood samples. Exp. Parasitol. 2000;95:163–169. [PubMed] 18. Drew D.R., Reece S.E. Development of reverse-transcription PCR techniques to analyse the density and sex ratio of gametocytes in genetically diverse Plasmodium chabaudi infections. Mol. Biochem. Parasitol. 2007;156:199–209. [PubMed] 19. Abdel-Wahab A. Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. J. Infect. Dis. 2002;185:1838–1842. [PubMed] 20. Nassir E. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int. J. Parasitol. 2005;35:49–55. [PubMed] 21. Bousema J.T. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J. Infect. Dis. 2006;193:1151–1159. [PubMed] 22. Ouédraogo A.L. Age-dependent distribution of Plasmodium falciparum gametocytes quantified by pfs25 real-time QT-NASBA in a cross-sectional study in Burkina Faso. Am. J. Trop. Med. Hyg. 2007;76:626–630. [PubMed] 23. Shekalaghe S. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One. 2007;2:e1023. [PubMed] 24. Shekalaghe S.A. Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Trop. Med. Int. Health. 2007;12:547–553. [PubMed] 25. Nwakanma D. High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia. Int. J. Parasitol. 2008;38:219–227. [PubMed] 26. Schneider P. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am. J. Trop. Med. Hyg. 2007;76:470–474. [PubMed] 27. Jeffery G.M., Eyles D.E. Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am. J. Trop. Med. Hyg. 1955;4:781–789. [PubMed] 28. Graves P.M. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. Parasitology. 1988;96:251–263. [PubMed] 29. Bonnet S. Comparison of artificial membrane feeding with direct skin feeding to estimate infectiousness of Plasmodium falciparum gametocyte carriers to mosquitoes. Trans. R. Soc. Trop. Med. Hyg. 2000;94:103–106. [PubMed] 30. Boudin C. High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Am. J. Trop. Med. Hyg. 1993;48:700–706. [PubMed] 31. Schall J.J. Transmission success of the malaria parasite Plasmodium mexicanum into its vector: role of gametocyte density and sex ratio. Parasitology. 2000;121:575–580. [PubMed] 32. Gaillard F.O. Togetherness among Plasmodium falciparum gametocytes: interpretation through simulation and consequences for malaria transmission. Parasitology. 2003;127:427–435. [PubMed] 33. Paul R.E. Aggregation in malaria parasites places limits on mosquito infection rates. Infect. Genet. Evol. 2007;7:577–586. [PubMed] 34. Pichon G. High heterogeneity in the number of Plasmodium falciparum gametocytes in the bloodmeal of mosquitoes fed on the same host. Parasitology. 2000;121:115–120. [PubMed] 35. Babiker H.A. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am. J. Trop. Med. Hyg. 1998;59:582–590. [PubMed] 36. Billingsley P.F. Malaria parasite growth is stimulated by mosquito probing. Biol. Lett. 2005;1:185–189. [PubMed] 37. Shutler D. Rodent malaria parasites Plasmodium chabaudi and P. vinckei do not increase their rates of gametocytogenesis in response to mosquito probing. Proc. R. Soc. London Ser. B Biol. Sci. 2005;272:2397–2402. 38. Mideo N., Day T. On the evolution of reproductive restraint in malaria. Proc. R. Soc. London Ser. B Biol. Sci. 2008;275:1217–1224. 39. Buckling A. Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis. Exp. Parasitol. 1999;93:45–54. [PubMed] 40. Talman A.M. Influence of chemotherapy on the Plasmodium gametocyte sex ratio of mice and humans. Am. J. Trop. Med. Hyg. 2004;71:739–744. [PubMed] 41. Buckling A. Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology. 1999;118:339–346. [PubMed] 42. Buckling A.G. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proc. R. Soc. London Ser. B Biol. Sci. 1997;264:553–559. 43. Paul R.E.L. Sex determination in malaria parasites. Science. 2000;287:128–131. [PubMed] 44. Reece S.E. Host cell preference and variable transmission strategies in malaria parasites. Proc. R. Soc. London Ser. B Biol. Sci. 2005;272:511–517. 45. Targett G. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 2001;183:1254–1259. [PubMed] 46. Trager W., Gill G.S. Enhanced gametocyte formation in young erythrocytes by Plasmodium falciparum in vitro. J. Protozool. 1992;39:429–432. [PubMed] 47. Gautret P. Enhanced gametocyte formation by Plasmodium chabaudi in immature erythrocytes: pattern of production, sequestration, and infectivity to mosquitoes. J. Parasitol. 1996;82:900–906. [PubMed] 48. Robert V. Sex ratio of Plasmodium falciparum gametocytes in inhabitants of Dielmo, Senegal. Parasitology. 2003;127:1–8. [PubMed] 49. Reece S.E. Sex ratio adjustment and kin discrimination in malaria parasites. Nature. 2008;453:609–614. [PubMed] 50. Sokhna C.S. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine+pyrimethamine. Parasite. 2001;8:243–250. [PubMed] 51. Sowunmi A., Fateye B.A. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop. Med. Int. Health. 2003;8:783–792. [PubMed] 52. Akim N.I.J. Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. Am. J. Trop. Med. Hyg. 2000;63:199–203. [PubMed] 53. Ali E. Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 2006;100:176–183. [PubMed] 54. Bousema J.T. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malaria J. 2004;3:18. 55. Osorio L. Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia. Mem. Inst. Oswaldo Cruz. 2002;97:1221–1223. [PubMed] 56. Babiker H.A. Genetic diversity of Plasmodium falciparum in a village in eastern Sudan. 1. Diversity of enzymes, 2D-PAGE proteins and antigens. Trans. R. Soc. Trop. Med. Hyg. 1991;85:572–577. [PubMed] 57. Farnert A. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 1997;56:538–547. [PubMed] 58. Smith T. Premunition in Plasmodium falciparum infection: insights from the epidemiology of multiple infections. Trans. R. Soc. Trop. Med. Hyg. 1999;93:59–64. [PubMed] 59. Vardo A.M., Schall J.J. Clonal diversity of a lizard malaria parasite, Plasmodium mexicanum, in its vertebrate host, the western fence lizard: role of variation in transmission intensity over time and space. Mol. Ecol. 2007;16:2712–2720. [PubMed] 60. Jarvi S.I. Genetic characterization of Hawaiian isolates of Plasmodium relictum reveals mixed-genotype infections. Biol. Direct. 2008;3:25. [PubMed] 61. Hill W.G. Estimation of inbreeding coefficients from genotypic data on multiple alleles, and application to estimation of clonality in malaria parasites. Genet. Res. 1995;65:53–61. [PubMed] 62. Huber W. Genetic characterization of the malaria parasite Plasmodium falciparum in the transmission from the host to the vector. Parasitology. 1998;116:95–101. [PubMed] 63. de Roode J.C. Virulence and competitive ability in genetically diverse malaria infections. Proc. Natl. Acad. Sci. U. S. A. 2005;102:7624–7628. [PubMed] 64. Bell A.S. Within-host competition in genetically diverse malaria infections: parasite virulence and competitive success. Evolution. 2006;60:1358–1371. [PubMed] 65. Wargo A.R. Transmission stage investment of malaria parasites in response to in-host competition. Proc. R. Soc. London Ser. B Biol. Sci. 2007;274:2629–2638. 66. Farnert A. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans. R. Soc. Trop. Med. Hyg. 2001;95:225–232. [PubMed] 67. Read A.F. Gametocyte sex ratios as indirect measures of outcrossing rates in malaria. Parasitology. 1992;104:387–395. [PubMed] 68. Dye C., Godfray H.C. On sex ratio and inbreeding in malaria parasite populations. J. Theor. Biol. 1993;161:131–134. [PubMed] 69. Nee S. Inbreeding and parasite sex ratios. Proc. R. Soc. London Ser. B Biol. Sci. 2002;269:755–760. 70. Ferguson H.M., Read A.F. Why is the effect of malaria parasites on mosquito survival still unresolved? Trends Parasitol. 2002;18:256–261. [PubMed] 71. Shutler D., Read A.F. Local mate competition, and extraordinary and ordinary blood parasite sex ratios. Oikos. 1998;82:417–424. 72. Werren J.H. Sex ratio evolution under local mate competition in a parasitic wasp. Evolution. 1983;37:116–124. 73. Gardner A. Even more extreme fertility insurance and the sex ratios of protozoan blood parasites. J. Theor. Biol. 2003;223:515–521. [PubMed] 74. Schall J.J., Vardo A.M. Identification of microsatellite markers in Plasmodium mexicanum, a lizard malaria parasite that infects nucleated erythrocytes. Mol. Ecol. Notes. 2007;7:227–229. 75. Paul R.E.L. Plasmodium sex determination and transmission to mosquitoes. Trends Parasitol. 2002;18:32–38. [PubMed] 76. Dunyo S. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin. Trials. 2006;1:e20. [PubMed] 77. El-Sayed B. A randomized open-label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in Eastern Sudan. PLoS One. 2007;2:e1311. [PubMed] 78. Okell L.C. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar. J. 2008;7:125. [PubMed] 79. Bousema J.T. Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae. Am. J. Trop. Med. Hyg. 2008;78:442–448. [PubMed]
|
This article has been 
host environmental conditions
